!!Carlo Patrono - Curriculum vitae \\ __EDUCATION:__ \\ *1962 B.S, Arts, Liceo Classico Nazareno; Rome, Italy *1968 M.D.Cum Laude Catholic University School of Medicine, Rome, Italy *1969-1971 Postdoctoral Fellow Medicine Bronx Veterans Administration, Hospital and Mount Sinai, School of Medicine, New York, U.S.A. \\ __PROFESSIONAL EXPERIENCE:__ \\ *1972-1982 Assistant Professor, Department of Pharmacology, Catholic University School of Medicine, Rome *1983-1985 Associate Professor, Department of Pharmacology Catholic University School of Medicine, Rome *1984-1985 Lecturer in Medicine, Mount Sinai School of Medicine, New York, USA *1985-1986 Visiting Professor, Department of Pharmacology, King's College, London, Departments of Medicine (Cardiovascular Unit) and Clinical Pharmacology, Royal Postgraduate Medical School London, U.K. *1991-2001 Professor of Pharmacology University of Chieti, "G. D'Annunzio" School of Medicine *1996-1997 Visiting Professor of University of Pennsylvania Pharmacology School of Medicine, Philadelphia, USA *2001- Director, MIUR Center of “G. D’Annunzio” University Excellence on Aging Foundation, Chieti *2001-2006 Professor of Pharmacology University of Rome “La Sapienza” 2nd School of Medicine *2007- Professor and Chair of Pharmacology Catholic University School of Medicine, Rome \\ __PROFESSIONAL & SCIENTIFIC MEMBERSHIPS:__ \\ *Member of the Italian Society of Pharmacology, 1968- *Founding Member, Association for Patient-Oriented Research *Member of the Council on Arteriosclerosis, Thrombosis, and Vascular Biology of the American Heart Association *Honorary Member of the Association of American Physicians, 1991- *Fellow of the European Society of Cardiology, 1994- *Member of the Council on Thrombosis of the International Society and Federation of Cardiology, 1994-1996 *Chairman, Working Group "Thrombosis and Platelets" of the European Society of Cardiology, 1994-1996 *Member of the Advisory Committee of the General Clinical Research Center, University of Pennsylvania, 1996-1997 *Member of the Cardiovascular Review Committee, Commission of the European Communities, BIOMED Programme, 1997 *Fellow of the Royal College of Physicians in Ireland, 1998- *Chairman, Task Force on Antithrombotic Agents of the European Society of Cardiology, 2000-2003 and 2009- *External Advisor, NIH Center in Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 2000- *Chair, International COX-2 Study Group, 2002-2005 *Fellow of the Royal College of Physicians, 2003- *Member of Academia Europaea, 2004- *Member of Accademia Nazionale dei Lincei, 2004- \\ __AWARDS and HONORS:__ \\ *1980: Alexander B. Gutman Visiting Professorship of Medicine, awarded by the Mount Sinai School of Medicine, New York *1981: Upjohn Award "Excellence in Pharmacology" of the Italian Society of Pharmacology *1982: W.N. Creasy Visiting Professorship of Clinical Pharmacology, awarded by the Burroughs Wellcome Fund *1985: Senior Fellowship, awarded by the British Council *1998: International Aspirin® Senior Award, awarded by Bayer AG *2007: John Vane Award of the University of London \\ __EDITORIAL ACTIVITIES:__ \\ *Co-Editor of 7 books and journal issues (see list of publications). *Member of the Editorial Board of Clinical and Experimental Rheumatology (1982-present) *Member of the Editorial Board of the European Journal of Clinical Pharmacology (1984-2007) *Member of the Editorial Board of Trends in Cardiovascular Medicine (1990-1995) *Field Editor (Cardiovascular Pharmacology) of Pharmacological Research (1999-2008) *Member of the Editorial Board of Circulation (2000-present) *Member of the Editorial Board of Arteriosclerosis, Thrombosis and Vascular Biology (2002-present) *Member of the Editorial Advisory Board of Molecular Interventions, (2005-present) \\ __CURRENTLY FUNDED RESEARCH PROJECTS:__ \\ #European Commission, 6th Framework Programme, EICOSANOX “Eicosanoids and Nitric Oxide: Mediators of Cardiovascular, Cerebral & Neoplastic Diseases” 2005-2009 (Cluster Leader and Member of the Project Steering Committee) #“Antiplatelet Effects of a 12-hour Dosing Interval of Low-Dose Aspirin Administration in Patients with Type 2 Diabetes Mellitus and Enhanced Platelet Turnover” (2008-2010), funded by Bayer HealthCare AG (Principal Investigator) #“A Longitudinal Study of the Time-Course of Platelet Activation During the Development and Progression of Type 2 Diabetes Mellitus” (2009-2011), funded by Bayer HealthCare AG (Principal Investigator) #Innovative Medicines Initiative “Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools (SUMMIT)” (2009-2013) Co-Investigator \\ __CURRENT INSTITUTIONAL ACTIVITIES:__ \\ *Member of Consiglio Direttivo, Centro di Scienze dell’Invecchiamento, Fondazione Università “G. d’Annunzio” *Member of the Ethics Committee, Catholic University School of Medicine, Rome *Chair of the Drug Therapy Committee, Catholic University School of Medicine, Rome.